Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01517152 · ClinicalTrials.gov registry record

Testing a Spanish Version of a Patient Toxicity Questionnaire

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
112
Enrollment target

NCT01517152: Completed study, sponsored by National Cancer Institute (NCI).

NCT01517152 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01517152 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
112 participants
Enrollment target

Study Summary

Background: * The Common Terminology Criteria for Adverse Events (CTCAE) is a list of toxicities and side effects that may occur when people are having cancer treatment. Doctors and nurses use this list to describe the side effects patients experience from cancer treatment. We have developed a questionnaire to ask people having cancer treatment directly about common symptoms and side effects and to supply this information to their doctors and nurses. This questionnaire is known as PRO-CTCAE and is completed by a patient. * PRO-CTCAE was originally developed in English. Researchers want to develop a Spanish version of the patient questionnaire. To test whether the questions are well understood and whether it is easy to complete the questionnaire, the researchers will interview individuals whose primary language is Spanish and who are being treated for different types of cancer. Objectives: \- To test a Spanish version of the PRO-CTCAE questionnaire. Eligibility: \- Latinos at least 18 years of age who are having or have recently finished cancer treatments and whose main language is Spanish Design: * Participants will complete a questionnaire in Spanish with selected questions from the translated PRO-CTCAE. They will discuss their answers and any difficulties they might have had in understanding or answer the questions with an interviewer, who will take notes and record comments and suggestions. * Literacy is not required for this study. Participants may opt to have the questions read aloud to them by an interviewer.

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2012-01-04
Est. Completion 2018-10-09

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT01517152

The ClinicalTrials.gov registry entry for NCT01517152 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01517152 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01517152 about?

NCT01517152 is a clinical study titled "Testing a Spanish Version of a Patient Toxicity Questionnaire". Background: * The Common Terminology Criteria for Adverse Events (CTCAE) is a list of toxicities and side effects that may occur when people are having cancer treatment. Doctors and nurses use this list to describe the side effects patients experience from cancer treatment. We have developed a ques...

What is the current status of trial NCT01517152?

This trial is currently completed. The enrollment target is 112 participants. The study started on 2012-01-04. Estimated completion is 2018-10-09.

Who is sponsoring clinical trial NCT01517152?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.